J. Sarparanta

5.0k total citations
30 papers, 1.4k citations indexed

About

J. Sarparanta is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, J. Sarparanta has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Cardiology and Cardiovascular Medicine and 5 papers in Genetics. Recurrent topics in J. Sarparanta's work include Muscle Physiology and Disorders (18 papers), Cardiomyopathy and Myosin Studies (16 papers) and Neurogenetic and Muscular Disorders Research (5 papers). J. Sarparanta is often cited by papers focused on Muscle Physiology and Disorders (18 papers), Cardiomyopathy and Myosin Studies (16 papers) and Neurogenetic and Muscular Disorders Research (5 papers). J. Sarparanta collaborates with scholars based in Finland, France and Hungary. J. Sarparanta's co-authors include Peter Hackman, Anna Vihola, Bjarne Udd, Rajat Singh, Marina García‐Macía, Bjarne Udd, Isabelle Richard, Sylvie Marchand, Per Harald Jonson and Leena Peltonen and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Cell Metabolism.

In The Last Decade

J. Sarparanta

28 papers receiving 1.4k citations

Peers

J. Sarparanta

CCM

GENET

CMN

L. Palmucci Italy

Maire Leyne United States

Anne-Sophie Nicot France

Norma B. Romero France

Beate Schlotter‐Weigel Germany

Jens Reimann Germany

B. Alexander Yi United States

A. Nascimento Spain

Jean‐Pierre Revelli United States

Ikuya Nonaka Japan

L. Palmucci Italy

J. Sarparanta

778 ×0.7

357 ×0.6

CCM

111 ×0.5

GENET

143 ×0.7

237 ×1.1

CMN

Citations per year, relative to J. Sarparanta J. Sarparanta (= 1×) peers L. Palmucci

Countries citing papers authored by J. Sarparanta

Since Specialization

Citations

This map shows the geographic impact of J. Sarparanta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Sarparanta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Sarparanta more than expected).

Fields of papers citing papers by J. Sarparanta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Sarparanta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Sarparanta. The network helps show where J. Sarparanta may publish in the future.

Co-authorship network of co-authors of J. Sarparanta

This figure shows the co-authorship network connecting the top 25 collaborators of J. Sarparanta. A scholar is included among the top collaborators of J. Sarparanta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Sarparanta. J. Sarparanta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jokela, Manu, Sanna Huovinen, Cornelia Kornblum, et al.. (2025). Characterization of novel CASQ1 variants in two families with unusual phenotypic features. Journal of Neurology. 272(12). 789–789.

Felice, Kevin J., Per Harald Jonson, J. Sarparanta, et al.. (2024). Protein‐extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation. Annals of Clinical and Translational Neurology. 11(9). 2392–2405. 1 indexed citations

Sarparanta, J., Per Harald Jonson, Jens Reimann, et al.. (2023). Extension of the DNAJB2a isoform in a dominant neuromyopathy family. Human Molecular Genetics. 32(21). 3029–3039. 4 indexed citations

Johari, Mridul, Anna Vihola, Johanna Palmio, et al.. (2022). Comprehensive transcriptomic analysis shows disturbed calcium homeostasis and deregulation of T lymphocyte apoptosis in inclusion body myositis. Journal of Neurology. 269(8). 4161–4173. 14 indexed citations

Sarparanta, J., et al.. (2020). Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results. International Journal of Molecular Sciences. 21(4). 1409–1409. 48 indexed citations

Savarese, Marco, Johanna Palmio, Juan José Poza, et al.. (2019). Actininopathy: A new muscular dystrophy caused by ACTN2 dominant mutations. Annals of Neurology. 85(6). 899–906. 26 indexed citations

Palmio, Johanna, Per Harald Jonson, Michio Inoue, et al.. (2019). Mutations in the J domain of DNAJB6 cause dominant distal myopathy. Neuromuscular Disorders. 30(1). 38–46. 22 indexed citations

Toledo, Míriam, Ana Batista‐González, Elena Tarabra, et al.. (2018). Autophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1. Cell Metabolism. 28(2). 268–281.e4. 130 indexed citations

Savarese, Marco, J. Sarparanta, Anna Vihola, Bjarne Udd, & Peter Hackman. (2016). Increasing Role of Titin Mutations in Neuromuscular Disorders. Journal of Neuromuscular Diseases. 3(3). 293–308. 97 indexed citations

10.

Charton, Karine, J. Sarparanta, Anna Vihola, et al.. (2015). CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy. Human Molecular Genetics. 24(13). 3718–3731. 36 indexed citations

11.

Jonson, Per Harald, J. Sarparanta, H. Luque, & Bjarne Udd. (2012). G.P.38 The LGMD1D gene DNAJB6: Its role in sarcomeric protein maintenance and aggregation. Neuromuscular Disorders. 22(9-10). 830–831. 1 indexed citations

12.

Hackman, Peter, Satu Sandell, J. Sarparanta, et al.. (2011). Four new Finnish families with LGMD1D; refinement of the clinical phenotype and the linked 7q36 locus. Neuromuscular Disorders. 21(5). 338–344. 16 indexed citations

13.

Charton, Karine, Nathalie Danièle, Anna Vihola, et al.. (2010). Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Human Molecular Genetics. 19(23). 4608–4624. 30 indexed citations

14.

Sandell, Satu, Sanna Huovinen, J. Sarparanta, et al.. (2010). The enigma of 7q36 linked autosomal dominant limb girdle muscular dystrophy. Journal of Neurology Neurosurgery & Psychiatry. 81(8). 834–839. 21 indexed citations

15.

Sarparanta, J., Gaëlle Blandin, Karine Charton, et al.. (2010). Interactions with M-band Titin and Calpain 3 Link Myospryn (CMYA5) to Tibial and Limb-girdle Muscular Dystrophies. Journal of Biological Chemistry. 285(39). 30304–30315. 55 indexed citations

16.

Pénisson-Besnier, I., Peter Hackman, Tiina Suominen, et al.. (2010). Myopathies caused by homozygous titin mutations: limb-girdle muscular dystrophy 2J and variations of phenotype. Journal of Neurology Neurosurgery & Psychiatry. 81(11). 1200–1202. 29 indexed citations

17.

Sarparanta, J.. (2008). Biology of myospryn: what’s known?. Journal of Muscle Research and Cell Motility. 29(6-8). 177–180. 19 indexed citations

18.

Hackman, Peter, Sylvie Marchand, J. Sarparanta, et al.. (2008). Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD). Neuromuscular Disorders. 18(12). 922–928. 72 indexed citations

19.

Hackman, Peter, Vesa Juvonen, J. Sarparanta, et al.. (2004). Enrichment of the R77C α‐sarcoglycan gene mutation in finnish LGMD2D patients. Muscle & Nerve. 31(2). 199–204. 21 indexed citations

20.

Hackman, Peter, Anna Vihola, Henna Haravuori, et al.. (2002). Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin. The American Journal of Human Genetics. 71(3). 492–500. 310 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact